发明名称 |
AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS |
摘要 |
The disclosure provides a method to prevent, control, and/or treat opioid induced dysfunctions comprising administering to a patient in need a guanylate cyclase receptor agonist (GCRA) peptide. Compositions comprising guanylate cyclase receptor agonist (GCRA) peptides, methods of making, and methods of treatment are also disclosed. Further disclosed are the guanylate cyclase receptor agonist (GCRA) peptide and opioid formulated in the same composition. |
申请公布号 |
US2016220630(A1) |
申请公布日期 |
2016.08.04 |
申请号 |
US201415026563 |
申请日期 |
2014.10.10 |
申请人 |
SYNERGY PHARMACEUTICALS, INC. |
发明人 |
SHAILUBHAI Kunwar;PALEJWALA Vaseem |
分类号 |
A61K38/10;A61K45/06 |
主分类号 |
A61K38/10 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for preventing, treating a condition, or alleviating a symptom of an opioid induced dysfunction comprising administering to a subject in need thereof a therapeutically effective amount of a composition comprising a guanylate cyclase receptor agonist (GCRA) peptide consisting essentially of the amino acid sequence of any one of Tables 2-8. |
地址 |
New york NY US |